Skip to main content
. 2023 Nov 10;200(4):314–319. doi: 10.1007/s00066-023-02157-8

Table 6.

Toxicity data during follow-up

Fibrosis Grade 0 113/138 (81.9%)
Grade 1 21/138 (15.2%)
Grade 2 4/138 (2.9%)
Grade 3 0/116 (0%)
Grade 4 0/116 (0%)
Hyperpigmentation Grade 0 98/138 (71.0%)
Grade 1 34/138 (24.6%)
Grade 2 6/138 (4.4%)
Grade 3 0/138 (0%)
Grade 4 0/138 (0%)
Lymphedema breast Grade 0 120/138 (87.0%)
Grade 1 12/138 (8.7%)
Grade 2 6/138 (4.3%)
Grade 3 0/138 (0%)
Grade 4 0/138 (0%)
Lymphedema arm Grade 0 128/138 (92.7%)
Grade 1 7/138 (5.1%)
Grade 2 3/138 (2.2%)
Grade 3 0/138 (0%)
Grade 4 0/138 (0%)
Lung fibrosis Grade 0 135/138 (97.8%)
Grade 1 3/138 (2.2%)
Grade 2 0/138 (0%)
Grade 3 0/138 (0%)
Grade 4 0/138 (0%)